These results suggest that empagliflozin suppresses the ISGs induced by type I and type II IFNs in macrophages, and the influenza-induced IFN-mediated suppression of ISGs may be a mechanism that contributes to increased viral load during influenza infection. The gene discussed is IFNA1; the disease is influenza.